AU6417198A - Cytoprotective agents comprising monoamine oxidase inhibitors - Google Patents

Cytoprotective agents comprising monoamine oxidase inhibitors

Info

Publication number
AU6417198A
AU6417198A AU64171/98A AU6417198A AU6417198A AU 6417198 A AU6417198 A AU 6417198A AU 64171/98 A AU64171/98 A AU 64171/98A AU 6417198 A AU6417198 A AU 6417198A AU 6417198 A AU6417198 A AU 6417198A
Authority
AU
Australia
Prior art keywords
monoamine oxidase
oxidase inhibitors
cytoprotective agents
cytoprotective
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64171/98A
Inventor
Robert Mooney
Carmel Mothersill
Keith Tipton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioresearch Ireland A Division Of Eolas - Irish Science And Technology Agency
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Original Assignee
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Bioresearch Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin, Bioresearch Ireland filed Critical College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Publication of AU6417198A publication Critical patent/AU6417198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU64171/98A 1997-03-13 1998-03-13 Cytoprotective agents comprising monoamine oxidase inhibitors Abandoned AU6417198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE970189 1997-03-13
IE970189 1997-03-13
PCT/IE1998/000023 WO1998040102A1 (en) 1997-03-13 1998-03-13 Cytoprotective agents comprising monoamine oxidase inhibitors

Publications (1)

Publication Number Publication Date
AU6417198A true AU6417198A (en) 1998-09-29

Family

ID=11041418

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64171/98A Abandoned AU6417198A (en) 1997-03-13 1998-03-13 Cytoprotective agents comprising monoamine oxidase inhibitors

Country Status (4)

Country Link
EP (1) EP0975366A1 (en)
AU (1) AU6417198A (en)
CA (1) CA2284001A1 (en)
WO (1) WO1998040102A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1592301A (en) * 1999-11-11 2001-06-06 Fred Hutchinson Cancer Research Center Novel topoisomerase poisons for the treatment of proliferative disorders
US7173063B1 (en) 2000-11-10 2007-02-06 Fred Hutchinson Cancer Research Center Topoisomerase poisons for the treatment of proliferative disorders
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5930573B2 (en) 2007-03-01 2016-06-15 プロビオドルグ エージー New use of glutaminyl cyclase inhibitors
DK2142514T3 (en) 2007-04-18 2015-03-23 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
US20100189790A1 (en) 2009-01-23 2010-07-29 Teva Pharmaceutical Industries, Ltd. Delayed release rasagiline formulation
CA2772488C (en) 2009-09-11 2018-04-17 Probiodrug Ag Heterocyclic derivatives as inhibitors of glutaminyl cyclase
JP6026284B2 (en) 2010-03-03 2016-11-16 プロビオドルグ エージー Inhibitors of glutaminyl cyclase
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
EP2776020B1 (en) * 2011-11-09 2019-09-11 Teikoku Seiyaku Co., Ltd. Methods for the treatment of skin neoplasms
CA2809364A1 (en) * 2012-10-09 2014-04-09 Brandon University (-)-deprenyl and related compounds for the treatment of alopecia
ES2812698T3 (en) 2017-09-29 2021-03-18 Probiodrug Ag Glutaminyl cyclase inhibitors
EP3931189A4 (en) 2019-02-27 2022-11-30 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578687A1 (en) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
EP0906090A1 (en) * 1996-03-15 1999-04-07 Somerset Pharmaceuticals, Inc. Method for preventing and treating peripheral neurophathy by administering selegiline

Also Published As

Publication number Publication date
WO1998040102A1 (en) 1998-09-17
CA2284001A1 (en) 1998-09-17
EP0975366A1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
AU6477498A (en) Scale inhibitors
IL138387A0 (en) Enzyme inhibitors
ZA98376B (en) Sulfamide-metalloprotease inhibitors
EP1083913A4 (en) Monoamine oxidase (mao) inhibitors and uses thereof
GB2321641B (en) Sulfamide-metalloprotease inhibitors
AU6417198A (en) Cytoprotective agents comprising monoamine oxidase inhibitors
AU5991699A (en) Quinolizinones as integrin inhibitors
AU7349298A (en) Prostaglandin agonists
PL338330A1 (en) Cytokinic oxidase
AU9059798A (en) Urokinase inhibitors
AU7139598A (en) Protease inhibitors
AU1605699A (en) Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors (ii)
AU3344099A (en) Analgetic agent
AU2723099A (en) Tryptase inhibitors
AU7126900A (en) Enzyme inhibitors
AU1201500A (en) Novel chain transfer agents
AU8673598A (en) Neuraminidase inhibitors
AU9443898A (en) Wof inhibitor
AU3235100A (en) Prothease inhibitors
GB9924522D0 (en) Enzyme inhibitors
AU2656799A (en) Metal-thiols as imminomodulating agents
AU2849399A (en) Monobactam enzyme inhibitors
AU8997498A (en) Tryptase inhibitor
AU2373600A (en) Novel spla2 inhibitors
AU9300298A (en) Protease inhibitors